The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion (Q36301903)

13 August 2017

1 reference

title

The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion (English)

1 reference

13 August 2017

Terence H Rabbitts

2

0 references

author name string

Chang-Hoon Nam

series ordinal

1

1 reference

13 August 2017

language of work or name

1 reference

2 November 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

13

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

15-25

1 reference

Boveri and the early days of genetics

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Two complex translocations in chronic granulocytic leukemia involving chromosomes 22, 9, and a third chromosome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Chromosomal translocations in human cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Oncogenic conversion of transcription factors by chromosomal translocations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Translocations, master genes, and differences between the origins of acute and chronic leukemias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

The rhombotin gene family encode related LIM-domain proteins whose differing expression suggests multiple roles in mouse development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Identification of the LMO4 gene encoding an interaction partner of the LIM-binding protein LDB1/NLI1: a candidate for displacement by LMO proteins in T cell acute leukaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Identification and characterization of LMO4, an LMO gene with a novel pattern of expression during embryogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Oncogenic transcription factors in the human acute leukemias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Gene expression profiling in T-cell acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Report from the 2nd Stem Cell Clonality and Genotoxicity Retreat: St. Louis, MO, June 1, 2005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Gene therapy insertional mutagenesis insights

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Chance or necessity? Insertional mutagenesis in gene therapy and its consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

A common mechanism of chromosomal translocation in T- and B-cell neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Identification of a TAL1 Target Gene Reveals a Positive Role for the LIM Domain-Binding Protein Ldb1 in Erythroid Gene Expression and Differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

The LIM domain protein Lmo2 binds to AF6, a translocation partner of the MLL oncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

T-cell oncogene rhombotin-2 interacts with retinoblastoma-binding protein 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Thymic overexpression of Ttg-1 in transgenic mice results in T-cell acute lymphoblastic leukemia/lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Gradient of E2A activity in B-cell development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

The function of E- and Id proteins in lymphocyte development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Regulation of pT alpha gene expression by a dosage of E2A, HEB, and SCL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Helix-loop-helix (E2-5, HEB, TAL1 and Id1) protein interaction with the TCRalphadelta enhancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Functions of E2A-HEB heterodimers in T-cell development revealed by a dominant negative mutation of HEB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Identification of a highly specific surface marker of T-cell acute lymphoblastic leukemia and neuroblastoma as a new member of the transmembrane 4 superfamily

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

T cell tumorigenesis in Lmo2 transgenic mice is independent of V-D-J recombinase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Identification of genes potentially involved in LMO2-induced leukemogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Design and selection of novel Cys2His2 zinc finger proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Chromosomal translocation products engender new intracellular therapeutic technologies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Selection of antibodies for intracellular function using a two-hybrid in vivo system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

The intracellular antibody capture technology (IACT): towards a consensus sequence for intracellular antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Intracellular antibody capture technology: application to selection of intracellular antibodies recognising the BCR-ABL oncogenic protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

mec-3, a homeobox-containing gene that specifies differentiation of the touch receptor neurons in C. elegans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Novel cysteine-rich motif and homeodomain in the product of the Caenorhabditis elegans cell lineage gene lin-11.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Insulin gene enhancer binding protein Isl-1 is a member of a novel class of proteins containing both a homeo- and a Cys-His domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

The LIM domain is a modular protein-binding interface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

The LIM motif defines a specific zinc-binding protein domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Structure of the carboxy-terminal LIM domain from the cysteine rich protein CRP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Association of erythroid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

Single domain intracellular antibodies: a minimal fragment for direct in vivo selection of antigen-specific intrabodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.09.010

10.1016/J.YMTHE.2005.09.010

7 January 2021

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/27koltumhfgzdmr4nrfmmbo4yi

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_27koltumhfgzdmr4nrfmmbo4yi

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/27koltumhfgzdmr4nrfmmbo4yi

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/27koltumhfgzdmr4nrfmmbo4yi

1 reference